Jason V. Coloma, CEO: Maze Therapeutics MAZE Planned sale · Filed 07/01

Trade details

Type: Planned sale notice
Stock: Maze Therapeutics MAZE
Person: Jason V. ColomaCEO
Planned sale date: 26/07/01
Filed: 26/07/01

More to sell after $1.8M in 3 months

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 06/01~07/31

Jason V. Coloma's recent trades

Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$933.3K
34,501 sh
$933.3K
Filed 10/01
Traded 10/01
Jason V. ColomaCEO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$623.4K
23,497 sh
$623.4K
Filed 09/02
Traded 09/02
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$908.1K
34,501 sh
$908.1K
Filed 09/01
Traded 09/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$922.6K
34,501 sh
$922.6K
Filed 08/03
Traded 08/03
Jason V. ColomaCEO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$621.7K
23,865 sh
$621.7K
Filed 06/24
Traded 06/23

Jason V. Coloma, CEO — plans to sell 34,501 sh of Maze Therapeutics MAZE · $1M · around 07/01 · 10b5-1 plan | Whalegun